Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Fibroblastic Reticular Cells Control Conduit Matrix Deposition during Lymph Node Expansion.

Martinez VG, Pankova V, Krasny L, Singh T, Makris S, White IJ, Benjamin AC, Dertschnig S, Horsnell HL, Kriston-Vizi J, Burden JJ, Huang PH, Tape CJ, Acton SE.

Cell Rep. 2019 Nov 26;29(9):2810-2822.e5. doi: 10.1016/j.celrep.2019.10.103.

2.

Cell-Specific Labeling for Analyzing Bidirectional Signaling by Mass Spectrometry.

Tape CJ, Jørgensen C.

Methods Mol Biol. 2017;1636:219-234. doi: 10.1007/978-1-4939-7154-1_14.

PMID:
28730482
3.

The Heterocellular Emergence of Colorectal Cancer.

Tape CJ.

Trends Cancer. 2017 Feb;3(2):79-88. doi: 10.1016/j.trecan.2016.12.004. Review.

4.

Proteomics profiling of interactome dynamics by colocalisation analysis (COLA).

Mardakheh FK, Sailem HZ, Kümper S, Tape CJ, McCully RR, Paul A, Anjomani-Virmouni S, Jørgensen C, Poulogiannis G, Marshall CJ, Bakal C.

Mol Biosyst. 2016 Dec 20;13(1):92-105.

5.

Oncogenic KRAS Regulates Tumor Cell Signaling via Stromal Reciprocation.

Tape CJ, Ling S, Dimitriadi M, McMahon KM, Worboys JD, Leong HS, Norrie IC, Miller CJ, Poulogiannis G, Lauffenburger DA, Jørgensen C.

Cell. 2016 Jun 16;165(7):1818. doi: 10.1016/j.cell.2016.05.079. No abstract available.

6.

Systems Biology Analysis of Heterocellular Signaling.

Tape CJ.

Trends Biotechnol. 2016 Aug;34(8):627-637. doi: 10.1016/j.tibtech.2016.02.016. Epub 2016 Apr 14.

PMID:
27087613
7.

Oncogenic KRAS Regulates Tumor Cell Signaling via Stromal Reciprocation.

Tape CJ, Ling S, Dimitriadi M, McMahon KM, Worboys JD, Leong HS, Norrie IC, Miller CJ, Poulogiannis G, Lauffenburger DA, Jørgensen C.

Cell. 2016 May 5;165(4):910-20. doi: 10.1016/j.cell.2016.03.029. Epub 2016 Apr 14. Erratum in: Cell. 2016 Jun 16;165(7):1818.

8.

Microenvironmental Heterogeneity Parallels Breast Cancer Progression: A Histology-Genomic Integration Analysis.

Natrajan R, Sailem H, Mardakheh FK, Arias Garcia M, Tape CJ, Dowsett M, Bakal C, Yuan Y.

PLoS Med. 2016 Feb 16;13(2):e1001961. doi: 10.1371/journal.pmed.1001961. eCollection 2016 Feb.

9.

Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells.

Caiazza F, McGowan PM, Mullooly M, Murray A, Synnott N, O'Donovan N, Flanagan L, Tape CJ, Murphy G, Crown J, Duffy MJ.

Br J Cancer. 2015 Jun 9;112(12):1895-903. doi: 10.1038/bjc.2015.163. Epub 2015 May 26.

10.

Reproducible automated phosphopeptide enrichment using magnetic TiO2 and Ti-IMAC.

Tape CJ, Worboys JD, Sinclair J, Gourlay R, Vogt J, McMahon KM, Trost M, Lauffenburger DA, Lamont DJ, Jørgensen C.

Anal Chem. 2014 Oct 21;86(20):10296-302. doi: 10.1021/ac5025842. Epub 2014 Oct 2.

11.

Cell-specific labeling enzymes for analysis of cell-cell communication in continuous co-culture.

Tape CJ, Norrie IC, Worboys JD, Lim L, Lauffenburger DA, Jørgensen C.

Mol Cell Proteomics. 2014 Jul;13(7):1866-76. doi: 10.1074/mcp.O113.037119. Epub 2014 May 12.

12.

Development of a 'mouse and human cross-reactive' affinity-matured exosite inhibitory human antibody specific to TACE (ADAM17) for cancer immunotherapy.

Kwok HF, Botkjaer KA, Tape CJ, Huang Y, McCafferty J, Murphy G.

Protein Eng Des Sel. 2014 Jun;27(6):179-90. doi: 10.1093/protein/gzu010. Epub 2014 Apr 24.

PMID:
24769623
13.

Anti-tumour effects of a specific anti-ADAM17 antibody in an ovarian cancer model in vivo.

Richards FM, Tape CJ, Jodrell DI, Murphy G.

PLoS One. 2012;7(7):e40597. doi: 10.1371/journal.pone.0040597. Epub 2012 Jul 11.

14.

Cross-domain inhibition of TACE ectodomain.

Tape CJ, Willems SH, Dombernowsky SL, Stanley PL, Fogarasi M, Ouwehand W, McCafferty J, Murphy G.

Proc Natl Acad Sci U S A. 2011 Apr 5;108(14):5578-83. doi: 10.1073/pnas.1017067108. Epub 2011 Mar 17.

15.

Thiol isomerases negatively regulate the cellular shedding activity of ADAM17.

Willems SH, Tape CJ, Stanley PL, Taylor NA, Mills IG, Neal DE, McCafferty J, Murphy G.

Biochem J. 2010 May 27;428(3):439-50. doi: 10.1042/BJ20100179.

PMID:
20345372

Supplemental Content

Support Center